MedTrace Logo

Dexmedetomidine Infusion as an Analgesic Adjuvant During Laparoscopic Cholecystectomy

NCT03211871 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2017-07-07

No results posted yet for this study

Summary

The aim of this study was to evaluate efficacy and safety of dexmedetomidine infusion during laparoscopic cholecystectomy. The randomized, single-center, controlled study was carried out from May 2016 to June 2017 at department of surgery, anesthesiology and intensive care, Postgraduate Institute of Bogomolets National Medical University.

Conditions

  • Pain, Postoperative

Interventions

DRUG

Dexmedetomidine

Intraoperative intravenous dexmedetomidine infusion 0,5 mcg/kg/h

DRUG

Normal Saline Flush, 0.9% Injectable Solution_#1

Intraoperative intravenous normal saline infusion

Sponsors & Collaborators

  • Bogomolets National Medical University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2017-08-01
Completion
2017-10-01

Countries

  • Ukraine

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03211871 on ClinicalTrials.gov